News Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 11, 2026 Posted by Pharvaris, Inc.
News Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares May 11, 2026 Posted by Pharvaris, Inc.
News Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency May 08, 2026 Posted by Anagram Therapeutics
News Monash University establishes Boston-based Hub to expedite drug discovery and innovation May 01, 2026 Posted by Monash University
Whitepapers Biotech Leaders Invited to Shape the Future of Sustainable Cold Chain Packaging May 01, 2026 Posted by ThermoSafe
News Calluna Pharma Completes Enrollment in Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis (IPF) Apr 30, 2026 Posted by Calluna Pharma
News CMS and FDA Announce RAPID Coverage Pathway to Accelerate Medicare Coverage for Breakthrough Medical Devices Apr 29, 2026 Posted by Foley Hoag LLP
.png)